Therakos, Inc. Launches Lighting Up Lives Anniversary Campaign to Celebrate 25-Year Impact of Innovative Immune Modulation Therapy
Published: Apr 02, 2012
GENEVA--(BUSINESS WIRE)--Therakos, Inc., a pioneer in the development of an innovative immune modulation therapy called extracorporeal photopheresis (ECP), today launched Lighting Up Lives, a 25-year anniversary campaign and year-long global initiative that honours the lives of patients with serious immune diseases impacted by ECP, as well as the healthcare professionals, caregivers and treatment centres that support them every step of the way. For a quarter century, ECP has been a valuable option for patients suffering from immune diseases, including graft-versus-host (GvHD), Crohn’s disease, cutaneous T-cell lymphoma (CTCL) and solid organ transplant (SOT) rejection, that are unresponsive to other therapies. Therakos is urging everyone to join the celebration by recognising the lives transformed, and the support teams dedicated to bringing light into the lives of so many.